Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Additionaly, Adhansia, Adlon, ALS, amyotrophic, Anatomic, antagonist, anticholinergic, appeal, argued, arithmetic, Bid, burden, Cap, cerebral, chapping, chronic, Circuit, concession, correspondingly, corridor, covertly, deadline, dehydration, diversify, drooling, excessive, explained, fifteen, fluid, foul, furlough, GDPR, Gerald, greatly, harbor, HCl, hereof, HHS, infection, inseverable, Inspector, Ironshore, Jornay, KemPharm, leadership, logistic, main, McLaughlin, mental, metabolite, micro, microparticle, molecule, month, motion, muscarinic, negligible, NeuRx, Northern, NRX, odor, OIG, ompany, oppose, Osomotica, overtly, oxybutynin, PA, palsy, parent, perioral, permission, Pharma, PM, pocket, pre, prolonged, psychosocial, Purdue, realigned, realignment, recasting, receptor, retardation, retention, ROU, salivation, shut, shutdown, sialorrhea, slight, ST, step, stigmatization, stranded, Takeda, therapy, timeframe, unclear, undertaken, upfront, urological, Vermont, worldwide, wrote
Filing tables
Filing exhibits
Related press release
Associated NEOS transcripts
NEOS similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-228748, No. 333-219108 and No. 333-212809) and Form S-8 (No. 333-226044, No. 333-223696, No. 333-216698, No. 333-210267 and No. 333-205937) of Neos Therapeutics, Inc. of our report dated March 18, 2019, relating to the consolidated financial statements and the financial statement schedule of Neos Therapeutics, Inc. appearing in this Annual Report on Form 10-K of Neos Therapeutics, Inc. for the year ended December 31, 2018.
/s/ RSM US LLP
Dallas, Texas
March 18, 2019
Consent of Independent Registered Public Accounting Firm